• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底动脉或椎动脉狭窄患者支架置入术后卒中发生率更高吗?

Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting?

机构信息

Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

J Neurointerv Surg. 2010 Mar;2(1):50-4. doi: 10.1136/jnis.2009.000356. Epub 2009 Dec 4.

DOI:10.1136/jnis.2009.000356
PMID:21990559
Abstract

BACKGROUND AND AIM

Posterior circulation stenosis may be a risk factor associated with stroke after intracranial stenting as compared with anterior circulation stenosis. Our aim was to test our hypothesis that there was no difference in clinical outcome poststenting between patients with severe stenosis of the basilar artery (BA) and intracranial vertebral artery (VA).

METHODS

Using the Cox proportional hazards regression model adjusted for prespecified factors (qualifying event, and timing of stenting after the qualifying event), we compared primary endpoint (ischemic stroke in the vertebrobasilar territory, including any stroke or death within 30 days of stenting) between patients with severe symptomatic atherosclerotic BA and VA stenosis who underwent elective stenting in our prospective database. Analysis was by intention-to-treat principle.

RESULTS

Primary endpoint event occurred in 13 (18.8%) of 69 patients with BA stenosis during a mean 23.4 months (9 within 30 days and 4 afterward) and 3 (4.3%) of 70 patients with VA stenosis during a mean 26.4 months (2 within 30 days and 1 afterward). Patients with BA stenosis had a significantly higher risk of the primary endpoint (adjusted HR=4.87, 95% CI 1.37 to 17.29; p=0.014) or any stroke or death within 30 days of stenting (adjusted HR=5.13, 95% CI 1.10 to 23.96; p=0.038) than those with VA stenosis.

CONCLUSION

A significantly higher stroke risk poststenting exists in patients with severe BA stenosis than those with VA stenosis. The discrepancy in clinical outcome after stenting between patients with BA and VA stenosis should be considered in clinical practice and stenting trials.

摘要

背景与目的

与前循环狭窄相比,后循环狭窄可能是颅内支架置入术后中风的一个危险因素。我们的目的是验证我们的假设,即基底动脉(BA)和颅内椎动脉(VA)严重狭窄患者支架置入后的临床结局没有差异。

方法

使用 Cox 比例风险回归模型,调整了预设因素( qualifying event 和支架置入时间),我们比较了在我们前瞻性数据库中接受择期支架置入的严重症状性动脉粥样硬化 BA 和 VA 狭窄患者的主要终点(椎基底动脉区域的缺血性中风,包括支架置入后 30 天内的任何中风或死亡)。分析采用意向治疗原则。

结果

13 例(18.8%)BA 狭窄患者在平均 23.4 个月(9 例在 30 天内,4 例在 30 天后)发生主要终点事件,70 例 VA 狭窄患者中有 3 例(4.3%)在平均 26.4 个月(2 例在 30 天内,1 例在 30 天后)发生主要终点事件。BA 狭窄患者发生主要终点事件的风险显著高于 VA 狭窄患者(调整后的 HR=4.87,95%CI 1.37 至 17.29;p=0.014)或支架置入后 30 天内任何中风或死亡的风险(调整后的 HR=5.13,95%CI 1.10 至 23.96;p=0.038)。

结论

与 VA 狭窄患者相比,BA 严重狭窄患者支架置入后中风风险显著增加。在临床实践和支架置入试验中,应考虑 BA 和 VA 狭窄患者支架置入后临床结局的差异。

相似文献

1
Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting?基底动脉或椎动脉狭窄患者支架置入术后卒中发生率更高吗?
J Neurointerv Surg. 2010 Mar;2(1):50-4. doi: 10.1136/jnis.2009.000356. Epub 2009 Dec 4.
2
Nonfocal symptoms are more frequent in patients with vertebral artery than carotid artery stenosis.椎动脉狭窄患者比颈动脉狭窄患者更常出现非局灶性症状。
Cerebrovasc Dis. 2013;35(4):378-84. doi: 10.1159/000348849. Epub 2013 Apr 30.
3
Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.症状性椎动脉狭窄患者的支架置入与药物治疗:一项随机开放标签 2 期试验。
Lancet Neurol. 2015 Jun;14(6):606-14. doi: 10.1016/S1474-4422(15)00017-4. Epub 2015 Apr 20.
4
Stenting of symptomatic basilar and vertebral artery stenosis in patients resistant to optimal medical prevention: the lyon stroke unit experience.对最佳药物预防治疗无效的症状性基底动脉和椎动脉狭窄患者的支架置入术:里昂卒中单元的经验
Eur Neurol. 2008;60(3):127-31. doi: 10.1159/000144082. Epub 2008 Jul 14.
5
Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.重度与中度颅内动脉粥样硬化狭窄择期支架置入术的比较
Neurology. 2007 Feb 6;68(6):420-6. doi: 10.1212/01.wnl.0000252939.60764.8e.
6
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.有症状的颅内动脉狭窄区域缺血性卒中的预测因素。
Circulation. 2006 Jan 31;113(4):555-63. doi: 10.1161/CIRCULATIONAHA.105.578229. Epub 2006 Jan 23.
7
Stenting for symptomatic intracranial vertebrobasilar artery stenosis: 30-day results in a high-volume stroke center.症状性颅内椎基底动脉狭窄的支架置入术:在一个大容量卒中中心的30天结果
Clin Neurol Neurosurg. 2016 Apr;143:132-8. doi: 10.1016/j.clineuro.2016.02.029. Epub 2016 Feb 22.
8
Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT.症状性椎动脉狭窄患者行椎动脉支架置入术预防卒中复发的 VIST RCT 研究
Health Technol Assess. 2019 Aug;23(41):1-30. doi: 10.3310/hta23410.
9
Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis.症状性颅内椎基底动脉狭窄择期支架置入术的长期疗效
Neurology. 2007 Mar 13;68(11):856-8. doi: 10.1212/01.wnl.0000256713.23864.be.
10
Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.88例接受颅内支架置入治疗的患者,存在症状性颅内椎动脉粥样硬化狭窄(≥70%)且对侧伴有椎动脉粥样硬化疾病。
Eur J Radiol. 2015 Sep;84(9):1801-4. doi: 10.1016/j.ejrad.2015.05.033. Epub 2015 Jun 5.

引用本文的文献

1
Recanalization of atherosclerotic stenosis and occlusion of intracranial vertebrobasilar artery.颅内椎基底动脉粥样硬化性狭窄及闭塞的再通
IBRO Neurosci Rep. 2024 Dec 31;18:88-95. doi: 10.1016/j.ibneur.2024.12.016. eCollection 2025 Jun.
2
Percutaneous transluminal angioplasty and stenting (PTAS) in patients with symptomatic intracranial vertebrobasilar artery stenosis (IVBS).有症状的颅内椎基底动脉狭窄(IVBS)患者的经皮腔内血管成形术和支架置入术(PTAS)。
Stroke Vasc Neurol. 2025 Apr 29;10(2):e003224. doi: 10.1136/svn-2024-003224.
3
Effects and safety of endovascular recanalization for non-acute symptomatic intracranial vertebral artery occlusion with different risks.
不同风险程度的非急性症状性颅内椎动脉闭塞血管内再通的效果和安全性。
Medicine (Baltimore). 2024 Feb 16;103(7):e36813. doi: 10.1097/MD.0000000000036813.
4
Endovascular Treatment of Symptomatic Basilar Artery Stenosis.症状性基底动脉狭窄的血管内治疗
Neurointervention. 2023 Nov;18(3):166-171. doi: 10.5469/neuroint.2023.00437. Epub 2023 Oct 19.
5
Percutaneous transluminal angioplasty and/or stenting for the treatment of basilar artery stenosis: a systematic review and meta-analysis.经皮腔内血管成形术和/或支架置入术治疗基底动脉狭窄:系统评价和荟萃分析。
Neuroradiology. 2023 Jun;65(6):985-1000. doi: 10.1007/s00234-023-03124-x. Epub 2023 Mar 7.
6
A Retrospective Study Comparison Between Stenting and Standardized Medical Treatment for Intracranial Vertebrobasilar Stenosis in a Real-World Chinese Cohort.一项针对中国真实世界队列中颅内椎基底动脉狭窄的支架置入术与标准化药物治疗的回顾性研究比较
Front Neurol. 2021 May 31;12:629644. doi: 10.3389/fneur.2021.629644. eCollection 2021.
7
Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke.颅内狭窄血管内支架治疗:预防致残性或致死性卒中的潜在未来。
Stroke Vasc Neurol. 2018 Jun 18;3(3):140-146. doi: 10.1136/svn-2018-000158. eCollection 2018 Sep.
8
Center volume and the outcomes of percutaneous transluminal angioplasty and stenting in patients with symptomatic intracranial vertebrobasilar stenoses: A meta-analysis.症状性颅内椎基底动脉狭窄患者经皮腔内血管成形术和支架置入术的中心容积与结局:一项荟萃分析。
PLoS One. 2018 Jul 10;13(7):e0200188. doi: 10.1371/journal.pone.0200188. eCollection 2018.
9
Intracranial artery stenosis: Current status of evaluation and treatment in China.颅内动脉狭窄:中国的评估与治疗现状
Chronic Dis Transl Med. 2017 Nov 14;3(4):197-206. doi: 10.1016/j.cdtm.2017.09.003. eCollection 2017 Dec.
10
Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis : Perspective for future clinical trials.症状性基底动脉狭窄患者的腔内血管成形术和支架置入术与保守治疗的比较:对未来临床试验的展望
Clin Neuroradiol. 2018 Mar;28(1):33-38. doi: 10.1007/s00062-016-0528-x. Epub 2016 Aug 9.